Controversies on the treatment of alcohol withdrawal symptoms
Danish Medical Journal · 2026-08 · 1-11
DOI: 10.61409/a03260192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Danish Medical Journal, 2026-08. Verfasst von Ulrik Becker und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Public Health, University of Southern Denmark. Hauptthemen laut MEDLINE: Benzodiazepines, Substance Withdrawal Syndrome, Alcohol Withdrawal Delirium, Alcoholism.
Abstract (Originalsprache)
Alcohol withdrawal symptoms (AWS) are serious and seen in patients with severe alcohol problems reducing their alcohol intake. AWS is associated with a high morbidity and mortality, and – if untreated – with delirium, seizures, and increased severity of subsequent withdrawals. Benzodiazepines are the drugs of choice for treating AWS, and the dosage should be sufficient, preferably according to symptom scores. Experiencing AWS has no positive effects, and early detection and adequate treatment are crucial to the outcome. Medicine-free treatment of AWS is a thing of the past.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institute of Public Health, University of Southern Denmark.
- Alcohol and Substance Use Disorder Treatment Facility, Svendborg.
- Unit for Clinical Alcohol Research, Research Unit of Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark.
Zitieren
APA
Becker, U., Birkemose, I., & Nielsen, A. S. (2026). Controversies on the treatment of alcohol withdrawal symptoms. Danish Medical Journal, 1-11. https://doi.org/10.61409/a03260192
Vancouver
Becker U, Birkemose I, Nielsen AS. Controversies on the treatment of alcohol withdrawal symptoms. Danish Medical Journal. 2026:1-11. doi:10.61409/a03260192
BibTeX
@article{Becker2026,
author = {Becker, Ulrik and Birkemose, Inge and Nielsen, Anette Søgaard},
title = {Controversies on the treatment of alcohol withdrawal symptoms},
journal = {Danish Medical Journal},
year = {2026},
pages = {1--11},
doi = {10.61409/a03260192}
}
EUVIMED